Viewing Study NCT03366103


Ignite Creation Date: 2025-12-24 @ 7:40 PM
Ignite Modification Date: 2026-01-15 @ 7:09 PM
Study NCT ID: NCT03366103
Status: TERMINATED
Last Update Posted: 2023-10-17
First Post: 2017-12-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors
Sponsor:
Organization: